Long & Short Banner (2)

"There’ll be some blood no doubt about it… But we’ll come through..."

- David Bowie, Black Tie White Noise

This week has seen a marked pick up in volatility and more pronounced risk aversion, as an unexpected and perhaps unusual amalgamation of factors combined to create some very ‘noisy’ markets.

Most notably perhaps, was the interaction between social media chatroom(s) and specific low liquidity stocks with high short interest - as has been widely publicised in the press over recent days. These incredible short squeezes, brought about by what appears to be widespread and concurrent retail option purchases - leaving the market short gamma as well as short stock - resulted in significant losses for the short holders and as a result put downward pressure on the indices, as de-risking / de-grossing of positions saw longs sold to fund losses on shorts.

Further, this week's FOMC meeting brought with it a more sober near-term economic narrative, as Chair Powell described the recent months’ economic and labour market progress as having “moderated”. Further, Powell described the downside risks from the virus as remaining “considerable”, as the economy remains a long way from a full recovery. However, Powell also dampened hopes of a more responsive monetary reaction function by suggesting that the FOMC will look through “transient” rises in inflation over coming months and will aim to maintain accommodation below ‘full employment’, in order to address equality in the workforce (in line with their new asymmetric maximum employment and symmetric inflation target under AIT). Ultimately, therefore, the Fed pledge to maintain accommodation is a modestly dovish iteration at the January FOMC. At the same time, the Biden administration continues to push for additional significant fiscal policy that should provide further underpinning of consumption and earnings growth through 2021.

On the virus front, there has also been something of a wobble in sentiment. Over recent sessions there has been a deterioration in the balance between the near-term virus trajectory (which has disappointed in many regions with extensions of lockdown restrictions across Europe and some tightening across Asia) and the expectations of uniform and significant vaccine production, expansion, and rollout. This has been highlighted not just in the disparity of vaccine rollouts between countries, but also in the recent spat between the EU and a coule of the major vaccine producers, about production expansion difficulties / delivery delays.

Finally, the release of the tech behemoth results last night was also taken as a trigger to sell equities, as after-hours indicators suggested. However, while there may have been some modest disappointments in some of the earnings metrics, there were also some very impressive statistics. I am not going to try and debate the implications of these results relative to the current valuation levels of these stocks, but against the current backdrop, I find it difficult to see how these figures detract from the case for these globally dominant tech innovators with demonstrable future earnings and huge cash holdings… at least not yet.

Overall, therefore, I feel that it boils down to a question of positioning, sentiment and conviction. There are some signs of recent moderation in growth and deterioration in virus dynamics. However, there are also signs of less scarring and lower credit deterioration (as Powell also noted). Further, as UK PM Johnson announced in the House of Commons on Wednesday, the UK expects to begin reopening, starting with schools, from early March. This is hopefully the first step to a sustainable (vaccination-driven) path to normality, a normality that due to the external nature of the shock could see a faster recovery than previous recessions (even an overshoot on pent-up demand in some sectors).

It would be remiss not to maintain a closer eye on market developments in the near term (including the technical adjustments to individual stock movements), but from our perspective, the macro backdrop remains positive - monetary accommodation, fiscal stimulus, well behaved credit metrics and hope of a (relatively) orderly global vaccine rollout.

To analogise the David Bowie song (today’s title), high levels of White Noise may persist for a while longer, but for now at least, we are reluctant to remove the Black Tie synonymous with the recent (US tech led) risk asset celebrations.

Disclosure

This communication is issued by Eurizon SLJ Capital Limited (“ESLJ”), a private limited company registered in England (company number: 09775525) having its registered office at 90 Queen Street, London EC4N 1SA, United Kingdom. ESLJ is authorised and regulated by the Financial Conduct Authority (FRN: 736926). This communication is treated as a marketing communication intended for professional investors only and is provided only for information purposes. It has not been prepared in accordance with legal and regulatory requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. It does not constitute research on investment matters and should not be construed as containing any recommendation, advice or suggestion, implicit or explicit, with respect to any investment strategy or financial instruments, or the issuers of any financial instruments, or a solicitation, offer or financial promotion relating to any securities or investments. ESLJ and its affiliates do not assume any liability whatsoever for the contents of this communication, save to the extent agreed in any written contract entered into between ESLJ and the recipient, and do not make any representation or warranty as to the accuracy or completeness of any information contained in this communication. Views are accurate as at the time of publication. Opinions expressed by individuals are their own and do not necessarily reflect those of ESLJ or any of its affiliates. The value of any investment may change and an investor may not get back the original amount invested. Past performance is not an indicator of future performance. This communication may not be reproduced, redistributed or copied in whole or in part for any purpose. It may not be distributed in any jurisdiction where its distribution may be restricted by law and persons into whose possession this communication comes should inform themselves about, and observe, any such restrictions.

ESLJ-290121-II

Our Research

Our written research products aim to provide unique and orthogonal insights on key global economic and policy issues in a timely fashion.

research page photo